| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/30/2004 | US20040191305 Entrapping in phosphatidylcholine component; room temperature transdermal delivery system; long shelf life |
| 09/30/2004 | US20040191303 Inhibiting adhesion of cells to activated vascular endothelium from bloodstream; proteins and glycoproteins isolated from human or animal amniotic fluid, serum or urine |
| 09/30/2004 | US20040191302 Fluidized bed dry air suspension; static spray gun atomizing; preventing agglomeration; solvent free |
| 09/30/2004 | US20040191301 Drug delivery patch; heat controlled release of suspended medication; steeply accelerating rate curve; contains antidrug theft antagonist in barrier that liquifies when heated to boiling water temperature |
| 09/30/2004 | US20040191298 Oral pharmaceuticals combined with cocoa butter; taste masking; rapid mouth disintegration delivery without fluid consumption |
| 09/30/2004 | US20040191297 Carotenoid formulation |
| 09/30/2004 | US20040191293 Controlled morphologies in polymer drug for release of drugs from polymer films |
| 09/30/2004 | US20040191284 Self-emulsifying compositions, methods of use and preparation |
| 09/30/2004 | US20040191281 Carrier matrix having open pores or capillary spaces serving as liquid reservoir; does not require uniform distribution |
| 09/30/2004 | US20040191277 Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use |
| 09/30/2004 | US20040191276 Compositions and kits for compounding pharmaceuticals |
| 09/30/2004 | US20040191250 Targeting conjugate with entrapped drug comprising lipid with polar head and hydrophobic tail attached to hydrophilic polymer and a targeting ligand to polymer; incubation; target-cell sensitized |
| 09/30/2004 | US20040191243 Solid may comprise excipient of mannitol, polysorbate, succinate, citrate, Tris, phosphate, trehalose, amino acids, polyoxyethylene glyclol, albumins, sucrose, lactose, maltose, and/or sorbitol; kits; monoclonal antibodies; freeze drying |
| 09/30/2004 | US20040191227 Induction of immunological tolerance |
| 09/30/2004 | US20040191225 Injecting isolated cell through needle into organ, tissue, or tumor; drug delivery; carrier aids in retention of cells at injection site, or a tissue sealant or film to seal; tissue engineering; gene therapy |
| 09/30/2004 | US20040191224 Storage in container; applying to a surface to be sanitized with a dispersing mechanism; poultry processing, medical equipment, aircraft |
| 09/30/2004 | US20040191219 HSA-free formulations of interferon-beta |
| 09/30/2004 | US20040191218 Pharmaceutical compositions and methods for treating cancer |
| 09/30/2004 | US20040191217 Orally administering interferon-tau to intestinal tract to produce measureable increase in patient's blood level of 2*,5*-oligoadenylate synthetase (OAS); autoimmune disease, viral infection and cancer treatment |
| 09/30/2004 | US20040191212 Phosphate-binding polymers for oral administration |
| 09/30/2004 | US20040191207 Alpha-hydroxy acid ester drug delivery compositions and methods of use |
| 09/30/2004 | US20040191186 Porous particles comprising excipients for deep lung delivery |
| 09/30/2004 | US20040191185 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration |
| 09/30/2004 | US20040191184 Delivery of muscle relaxants through an inhalation route |
| 09/30/2004 | US20040191183 Delivery of antiemetics through an inhalation route |
| 09/30/2004 | US20040191182 Delivery of analgesics through an inhalation route |
| 09/30/2004 | US20040191181 Vaporization of diphenhydramine from solid for breathing administerig |
| 09/30/2004 | US20040191180 Breathing analgesics after vaporization for administering pain killer for headaches |
| 09/30/2004 | US20040191179 Breathing antidepressants from aerosols for administering bupropion by heating on a solid support |
| 09/30/2004 | US20040191178 Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine |
| 09/30/2004 | US20040191177 Solutions with glycerol or sorbitol and adjuvants with active material |
| 09/30/2004 | US20040191175 Radio-Opaque polymer biomaterials |
| 09/30/2004 | US20040191044 Systems, methods and apparatuses for manufacturing dosage forms |
| 09/30/2004 | US20040187865 Metered dose inhaler for fluticasone propionate |
| 09/30/2004 | US20040187770 Rotor-stator apparatus and process for the formation of particles |
| 09/30/2004 | DE10312763A1 Verfahren zur Herstellung einer SLN-Dispersion A process for preparing a SLN-dispersion |
| 09/30/2004 | DE10312346A1 Kontrolliertes Freisetzungssystem Controlled release system |
| 09/30/2004 | DE10260882A1 Dosieraerosole mit Lecithin als oberflächenaktiver Substanz MDIs containing lecithin as surfactant |
| 09/30/2004 | DE10211801B4 Kosmetische und pharmazeutische Zubereitungen enthaltend einen oxalkylierten Polyglycerinester Cosmetic and pharmaceutical preparations containing one alkoxylated polyglycerol |
| 09/30/2004 | CA2633287A1 Combinations of rapamycin or its derivatives and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases |
| 09/30/2004 | CA2519589A1 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 09/30/2004 | CA2519324A1 Medical devices with enhanced ultrasonic visibility |
| 09/30/2004 | CA2519300A1 Self-emulsifying compositions, methods of use and preparation |
| 09/30/2004 | CA2519225A1 Inactivated vibrio cholerae vaccine in tablet form |
| 09/30/2004 | CA2519211A1 Release control compositions |
| 09/30/2004 | CA2519208A1 Controlled release composition |
| 09/30/2004 | CA2519084A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 09/30/2004 | CA2519065A1 Large volume ex vivo electroporation method |
| 09/30/2004 | CA2518960A1 Sinus delivery of sustained release therapeutics |
| 09/30/2004 | CA2518836A1 Drug formulations having long and medium chain triglycerides |
| 09/30/2004 | CA2518734A1 A process for preparing sustained release tablets |
| 09/30/2004 | CA2518327A1 Liquid, aqueous, pharmaceutical compositions of factor vii polypeptides |
| 09/30/2004 | CA2517589A1 Method for preparing small particles |
| 09/30/2004 | CA2515110A1 A controlled release system for pharmaceutical food and nutraceutical use |
| 09/29/2004 | EP1462460A1 Non-aqueous absorbent and use thereof |
| 09/29/2004 | EP1462455A1 Novel peptides and medicinal uses thereof |
| 09/29/2004 | EP1462149A1 Medicament for the treatment of migraine based on phenazon |
| 09/29/2004 | EP1462132A1 Drug releasing elastic band and method |
| 09/29/2004 | EP1462127A1 Lubricious, drug-accommodating coating |
| 09/29/2004 | EP1462121A1 Plaster having laminated support |
| 09/29/2004 | EP1462118A1 Compositions including a visual marker and method of use thereof |
| 09/29/2004 | EP1462115A1 Edible capsules |
| 09/29/2004 | EP1462112A1 Remedies for dry eye and diseases associated with dry eye |
| 09/29/2004 | EP1462109A1 Hemostatic, emollient and lubricating preparations containing pork fat extract (lard) |
| 09/29/2004 | EP1462101A1 Drinkable preparation comprising ketoprofen and the use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain |
| 09/29/2004 | EP1462100A1 Composition comprising formoterol and a glucosorticosteroid |
| 09/29/2004 | EP1462099A1 Gel compositions for external use, pad materials and pad materials to be packed in blister containers |
| 09/29/2004 | EP1462098A1 Stabilised pharmaceutical composition comprising a non-steroidal anti-inflammatory agent and a prostaglandin |
| 09/29/2004 | EP1462097A1 Process for the preparation of enteric-coated and /or controlled-release medicaments containing active principles sensitive to gastrointestinal environment |
| 09/29/2004 | EP1462096A1 Methods and compositions for pulmonary delivery of insulin |
| 09/29/2004 | EP1462095A1 Method and apparatus for minimising heat, moisture and shear damage to drugs and other compositions |
| 09/29/2004 | EP1461360A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 09/29/2004 | EP1461122A2 Treatment of genitourinary tract disorders |
| 09/29/2004 | EP1461101A2 Metering valve and pharmaceutical metered dose inhaler and methods thereof |
| 09/29/2004 | EP1461091A2 Composition and method for decreasing upper respiratory airway resistance |
| 09/29/2004 | EP1461090A2 Composition and method for treatment of otitis media |
| 09/29/2004 | EP1461079A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 09/29/2004 | EP1461076A2 Methods and compositions for treating lesions of the respiratory epithelium |
| 09/29/2004 | EP1461059A1 Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts |
| 09/29/2004 | EP1461057A1 A topical anti-itch formulation and a process for the preparation thereof |
| 09/29/2004 | EP1461056A2 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| 09/29/2004 | EP1461044A1 Pharmaceutical compositions comprising active vitamin d compounds |
| 09/29/2004 | EP1461043A1 Oral pharmaceutical products containing 17 beta-estradiol-3 lower alkanoate, method of administering the same and process of preparation |
| 09/29/2004 | EP1461042A1 Use of desoxypeganine for treating clinical depression |
| 09/29/2004 | EP1461031A2 Formulations for oral administration of cromolyn sodium |
| 09/29/2004 | EP1461030A1 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma |
| 09/29/2004 | EP1461029A1 Taxane based compositions and methods of use |
| 09/29/2004 | EP1461026A2 Method for treating ocular hypertension |
| 09/29/2004 | EP1461024A1 Treatment of wounds and compositions employed |
| 09/29/2004 | EP1461021A1 Transdermal drug delivery system of strychnine, brucine, securinine and their salts |
| 09/29/2004 | EP1461020A1 Synthesis of small particles |
| 09/29/2004 | EP1461019A2 Bioadhesive drug delivery system with enhanced gastric retention |
| 09/29/2004 | EP1461018A2 Dual controlled release dosage form |
| 09/29/2004 | EP1461017A1 A pharmaceutical composition for controlled release of a beta-lactam antibiotic |
| 09/29/2004 | EP1461016A2 Modular systems for the controlled release of a substance with space and time control |
| 09/29/2004 | EP1461015A2 Compositions containing both sedative and non-sedative antihistamines |
| 09/29/2004 | EP1461014A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 09/29/2004 | EP1461013A2 Method of producing a nicotine composition |
| 09/29/2004 | EP1461000A2 Materials and methods for making improved micelle compositions |
| 09/29/2004 | EP1460998A2 Extended release pharmaceutical tablet of metformin |